Eagle Pharmaceuticals
EGRX
$4.54
Share price
-2.58%
Change (1 day)
-78.49%
Change (1 year)
Categories
Market capitalization of Eagle Pharmaceuticals (EGRX)
Market cap: $58.83 Million
As of May 2024 Eagle Pharmaceuticals has a market cap of $58.83 Million. This makes Eagle Pharmaceuticals the world's 7690th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Eagle Pharmaceuticals from 2014 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $58.83 M | -13.39% |
| 2023 | $67.92 M | -82.15% |
| 2022 | $0.38 B | -42.14% |
| 2021 | $0.65 B | 8.37% |
| 2020 | $0.60 B | -25.9% |
| 2019 | $0.81 B | 46.08% |
| 2018 | $0.56 B | -29.67% |
| 2017 | $0.79 B | -35.08% |
| 2016 | $1.22 B | -11.44% |
| 2015 | $1.38 B | 537.26% |
| 2014 | $0.21 B |
End of Day market cap according to different sources
On May 10th, 2024 the market cap of Eagle Pharmaceuticals was reported to be:
$58.83 Million
$58.83 Million
$58.96 Million
$58.83 Million
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $360.78 B | 613,165.36% | 🇺🇸 USA |
 Novartis NVS | $208.32 B | 354,013.63% | 🇨🇭 Switzerland |
 Eli Lilly LLY | $722.30 B | 1,227,683.41% | 🇺🇸 USA |
 Amgen AMGN | $166.37 B | 282,705.82% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $91.09 B | 154,748.75% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $92.71 B | 157,496.54% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $18.40 B | 31,185.62% | 🇮🇱 Israel |